Literature DB >> 11907213

Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles.

Scott L Butler1, Erik P Johnson, Frederic D Bushman.   

Abstract

Early steps of retroviral replication involve reverse transcription of the viral RNA to yield a linear double-stranded cDNA copy and then integration of the viral cDNA into a chromosome of the host cell. A portion of the viral cDNA can also follow nonproductive pathways in which it becomes circularized. In one pathway, the ends of the linear cDNA become joined together by the cellular nonhomologous DNA end-joining system to form two-long terminal repeat (2-LTR) circles. It has been argued that 2-LTR circles are quickly degraded in human immunodeficiency virus (HIV)-infected cells, allowing the presence of 2-LTR circles to be used as a marker for ongoing de novo infection in patients. Following this idea, detection of 2-LTR circles in patients undergoing successful highly active antiretroviral therapy has led to the proposal that viral replication persists despite treatment. We have used fluorescence-monitored PCR (Taqman) to quantitate the metabolism of HIV cDNA early after infection. Contrary to previous work, we find that 2-LTR circles are actually quite stable in experiments where confounding variables are controlled. Thus, studies relying on the lability of 2-LTR circles are open to reinterpretation. We also used the quantitative PCR methods to analyze the effects of MG132, a proteasome inhibitor, which revealed that viral complexes containing mostly completed cDNAs are the primary substrates for proteasome-mediated degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907213      PMCID: PMC136088          DOI: 10.1128/jvi.76.8.3739-3747.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle.

Authors:  S Song; P J Laipis; K I Berns; T R Flotte
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication.

Authors:  Theodore C Pierson; Tara L Kieffer; Christian T Ruff; Christopher Buck; Stephen J Gange; Robert F Siliciano
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

Authors:  M L Markert; C B Hicks; J A Bartlett; J L Harmon; L P Hale; M L Greenberg; G Ferrari; J Ottinger; A Boeck; A L Kloster; T M McLaughlin; K B Bleich; R M Ungerleider; H K Lyerly; W E Wilkinson; F S Rousseau; M E Heath-Chiozzi; J M Leonard; A T Haase; G M Shaw; R P Bucy; D C Douek; R A Koup; B F Haynes; D P Bolognesi; K J Weinhold
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

7.  Identification of a human recent thymic emigrant phenotype.

Authors:  R D McFarland; D C Douek; R A Koup; L J Picker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.

Authors:  P Bell; L J Montaner; G G Maul
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Authors:  A Follenzi; L E Ailles; S Bakovic; M Geuna; L Naldini
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

10.  Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

Authors:  M E Sharkey; I Teo; T Greenough; N Sharova; K Luzuriaga; J L Sullivan; R P Bucy; L G Kostrikis; A Haase; C Veryard; R E Davaro; S H Cheeseman; J S Daly; C Bova; R T Ellison; B Mady; K K Lai; G Moyle; M Nelson; B Gazzard; S Shaunak; M Stevenson
Journal:  Nat Med       Date:  2000-01       Impact factor: 87.241

View more
  121 in total

1.  Biphasic DNA synthesis in spumaviruses.

Authors:  Olivier Delelis; Ali Saïb; Pierre Sonigo
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication.

Authors:  Zhujun Ao; Kallesh Danappa Jayappa; Binchen Wang; Yingfeng Zheng; Sam Kung; Eric Rassart; Reinhard Depping; Matthias Kohler; Eric A Cohen; Xiaojian Yao
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

Review 3.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Fengwen Zhang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 7.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

8.  Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap.

Authors:  David J Garfinkel; Karen M Stefanisko; Katherine M Nyswaner; Sharon P Moore; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

9.  Persistence and dissemination of simian retrovirus type 2 DNA in relation to viremia, seroresponse, and experimental transmissibility in Macaca fascicularis.

Authors:  Roseanne C Wilkinson; Claire K Murrell; Rebecca Guy; Gail Davis; Joanna M Hall; David C North; Nicola J Rose; Neil Almond
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

Authors:  Renate König; Yingyao Zhou; Daniel Elleder; Tracy L Diamond; Ghislain M C Bonamy; Jeffrey T Irelan; Chih-Yuan Chiang; Buu P Tu; Paul D De Jesus; Caroline E Lilley; Shannon Seidel; Amanda M Opaluch; Jeremy S Caldwell; Matthew D Weitzman; Kelli L Kuhen; Sourav Bandyopadhyay; Trey Ideker; Anthony P Orth; Loren J Miraglia; Frederic D Bushman; John A Young; Sumit K Chanda
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.